首页/数据集/CD37 a safe Chimeric Antigen Receptor target to treat acute myeloid leukemia

CD37 a safe Chimeric Antigen Receptor target to treat acute myeloid leukemia

NIAID Data Ecosystem2026-05-01 收录

CAR-T细胞疗法

急性髓系白血病治疗

数据链接：

https://data.mendeley.com/datasets/rdkg26mfjw 数据链接链接失效反馈

官方服务：

资源简介：

CD37 a safe Chimeric Antigen Receptor target to treat acute myeloid leukemia - Raw data

应用场景：

创建时间：

2024-04-19

急性髓系白血病治疗

造血干细胞移植预后

Supplementary Table from Longitudinal Outcome over Two Decades of Unrelated Allogeneic Stem Cell Transplantation for Relapsed/Refractory Acute Myeloid Leukemia: An ALWP/EBMT Analysis

NIAID Data Ecosystem60

Unleashing cell-intrinsic inflammation as a strategy to kill AML blasts

急性髓系白血病治疗

肿瘤免疫机制

This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

NIAID Data Ecosystem40

Additional file 1 of Nonviral mcDNA-mediated bispecific CAR T cells kill tumor cells in an experimental mouse model of hepatocellular carcinoma

CAR-T细胞疗法

肝细胞癌模型

Additional file 1.

Figshare2024-02-28 更新30

CAR-T Therapy Market

CAR-T细胞疗法

市场预测

Global CAR-T Therapy comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential ma

IMR REPORTS40

Supplementary Data S2 from Rational Protein Design Yields a CD20 CAR with Superior Antitumor Efficacy Compared with CD19 CAR

CAR-T细胞疗法

肿瘤免疫治疗

List of gene names and FPKM values from bulk RNA-seq on T cells harvested from tumor-bearing mice (Fig. 4A-D, F and Supplementary Fig. S7).

NIAID Data Ecosystem40